DAMON RUNYON CLINICAL INVESTIGATOR AWARD FUNDING RESEARCH FOR EARLY CAREER MD’S AND MD/PHDS. RESEARCH PROJECT FUNDED IS THE INVESTIGATION OF A BIOMARKR PHASE 2 STUDY TO EVALUATE TARGETED THERAPY HARBORING SPECIFIC GENETIC ALTERATIONS.